Warning: Undefined array key "mm" in /www/wwwroot/www.ai-bt.com/si.php on line 10 Deprecated: trim(): Passing null to parameter #1 ($string) of type string is deprecated in /www/wwwroot/www.ai-bt.com/si.php on line 10 Challenges to Biomarker Testing for PD-1/PD-L1 Checkpoint Inhibitors for Lung Cancer.

× No keyword cloud information.

4 in total

1. PD-L1 immunohistochemical assays for assessment of therapeutic strategies involving immune checkpoint inhibitors in non-small cell lung cancer: a comparative study.

Authors: Hyojin Kim; Hyun Jung Kwon; Soo Young Park; Eunhyang Park; Jin-Haeng Chung
Journal: Oncotarget Date: 2017-10-06

Review 2. Pembrolizumab in the treatment of metastatic non-small-cell lung cancer: patient selection and perspectives.

Authors: Ashwin Somasundaram; Timothy F Burns
Journal: Lung Cancer (Auckl) Date: 2017-01-11

3. Establishing a complementary diagnostic for anti-PD-1 immune checkpoint inhibitor therapy.

Authors: J F Novotny; J Cogswell; H Inzunza; C Harbison; C Horak; S Averbuch
Journal: Ann Oncol Date: 2016-08-08 Impact factor: 32.976

4. Immunohistochemical assays incorporating SP142 and 22C3 monoclonal antibodies for detection of PD-L1 expression in NSCLC patients with known status of EGFR and ALK genes.

Authors: Paweł Krawczyk; Bożena Jarosz; Tomasz Kucharczyk; Anna Grenda; Katarzyna Reszka; Juliusz Pankowski; Kamila Wojas-Krawczyk; Marcin Nicoś; Justyna Szumiło; Tomasz Trojanowski; Janusz Milanowski
Journal: Oncotarget Date: 2017-07-31

4 in total